07th March 2022 | Pharma Updates
SEC recommends that Serum Institute of India's Covovax COVID-19 vaccine be granted emergency use authorization
Subject Expert Committee (SEC) has recommended that Serum India of India’s COVID-19 vaccine Covovax be given an emergency use authorization (EUA) for children aged 12 to 17.
Six drug companies are competing for Curatio, including Dr. Reddy's and Biocon
According to numerous sources familiar with the development, Aurobindo, Biocon, Dr Reddy’s, JB Chemicals, Torrent Pharma, and Zydus Healthcare have been shortlisted for the acquisition of Curatio Healthcare, a Chennai-based skincare company.
In pretreated metastatic breast cancer, Eribulin Elicits Promising 2-Year Overall Survival
Eribulin may be a successful treatment for previously treated patients with metastatic breast cancer, according to real-world findings presented at the 39th Annual Miami Breast Cancer Conference.
According to research published in Alzheimer's and Dementia, an NIH drug candidate decreases brain inflammation in mice
The findings add to the growing body of data that brain inflammation, which occurs decades before Alzheimer’s symptoms appear, is a critical neuropathological pathway of interest in the search for novel Alzheimer’s treatments.
FDA has approved the expanded use of Bristol Myers Squibb's cancer drug Opdivo
Bristol-Myers Squibb announced that the U.S. Food and Medicine Administration had approved the use of its cancer drug Opdivo in combination with chemotherapy as a first-line treatment for patients with an aggressive form of lung cancer.
Pfizer Canada recalls a BP medicine due to a possible cancer-causing contaminant
Long-term exposure to N-nitroso-quinapril at levels above what is deemed safe may raise the risk of cancer, according to Health Canada, while there is no immediate risk from using Accuretic.
United States is expected to share some Covid vax technologies with WHO
According to top federal health officials, the US is going to implement a strategy that will provide the World Health Organization (WHO) with access to technology that may be utilised by low and middle-income countries to develop treatments for Covid-19.
China will deal with Covid-19 clusters in a targeted, scientific manner
According to the report, the country would also increase research into coronavirus variations and their prevention, as well as speed research and development of vaccines and efficient COVID medications.
Novavax Moves a Step Closer to FDA Approval
After a large Phase 3 trial revealed 90% protection against symptomatic infection and 100% protection against severe disease, Novavax finally submitted a request for permission in late January, and a final agency decision is approaching.
Two approvals, three rejections, and one clinical hold have been issued by the FDA
In the last week, the FDA authorised medications from Johnson & Johnson and CTI BioPharma. Gilead Sciences, Amryt, and Reata Pharmaceuticals have all received complete response letters.
